The new central operational difference is the role of combination vaccines. Australia’s NIP uses combination products across infancy and early childhood, including hexavalent vaccines and the MMRV vaccine at 18 months. …
US childhood vaccine move away from combinations contrasts with Australia’s national schedule
August 12, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
ENA Respiratory secures funding to test antiviral nasal spray in people with asthma
September 2, 2026 - -
OncoSil pursues a reimbursement pathway as it prepares for US rollout
September 2, 2026 - - Australian Biotech -
Vitrafy takes its cryopreservation technology into the US cell therapy market
September 2, 2026 - - Australian Biotech -
Telix completes BiPASS enrolment as it pursues a broader role for PSMA PET
September 2, 2026 - - Australian Biotech -
Roche maps a new chapter with move to new Sydney CBD location
September 2, 2026 - - Latest News -
Priceline Pharmacy broadens women’s health support with new parenting program
September 2, 2026 - -
The non-disclosure agreement is just about creating a zone of controlled silence
September 2, 2026 -